Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Transmission-blocking malaria vaccines

Bathurst, I. C., Barr, P. J., Kaslow, D. C., Lewis, D. H., Atkins, T. J., and Rickey, M. E., 1992, Development of a single mjection transmission-blocking malaria vaccine using biodegradable microspheres, Proc. Int. Symp. Control Rel Bioact. Mater. 19 120-121. [Pg.83]

Kaslow, D., Shiloach, J. (1994) Production, Purification and Immunogenicity of a Malaria Transmission-Blocking Vaccine Candidate TBV25H Expressed in Yeast and Purified using Nickel-NTA Agarose. Biotechnology, 12, 494-499... [Pg.193]

Elimination of centrifugation and filtration in large industrial-scale isolations is a major driving force for the introduction of EBA in the isolation of therapeutic proteins. Streamline chelating (Amersham Pharmacia Biotech) has been tried to purify two vaccine candidates for clinical studies His6-tagged modified diphtheria toxin, expressed in E. coli, and malaria-transmission-blocking vaccine, secreted from S. cerevisiae ... [Pg.90]

Kaslow D.C. and Shiloach J. 1994. Production, purification and immunogenicity of a malaria transmission-blocking vaccine candidate TBV25H expressed in yeast and purified using nickel-NTA agarosa. Biotechnology, 12, 494. [Pg.100]

See other pages where Transmission-blocking malaria vaccines is mentioned: [Pg.105]    [Pg.4]    [Pg.4]    [Pg.236]    [Pg.84]    [Pg.90]    [Pg.618]    [Pg.36]   
See also in sourсe #XX -- [ Pg.4 ]



SEARCH



Malaria

Malaria, vaccines

Transmission-blocking malaria

© 2024 chempedia.info